Get the Stockscreener App
3.79
4.99%
0.18
Celularity Inc stock is traded at $3.79, with a volume of 48,756.
It is up +4.99% in the last 24 hours and up +1.34% over the past month.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
See More
Previous Close:
$3.61
Open:
$3.67
24h Volume:
48,756
Relative Volume:
0.22
Market Cap:
$90.77M
Revenue:
$48.20M
Net Income/Loss:
$-35.05M
P/E Ratio:
-2.4182
EPS:
-1.5673
Net Cash Flow:
$-13.02M
1W Performance:
+8.91%
1M Performance:
+1.34%
6M Performance:
+125.60%
1Y Performance:
+21.72%
1-Day Range:
$3.61
$3.98
1-Week Range:
$3.42
$4.31
52-Week Range:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Name
Celularity Inc
Sector
Industry
Phone
(908) 768-2170
Address
170 PARK AVE, FLORHAM PARK
Compare CELU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.79 | 99.39M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-22-22 | Initiated | H.C. Wainwright | Buy |
| Apr-06-22 | Downgrade | Truist | Buy → Hold |
| Jan-28-22 | Initiated | Oppenheimer | Outperform |
| Nov-24-21 | Initiated | Morgan Stanley | Equal-Weight |
View All
Celularity Inc Stock (CELU) Latest News
Celularity completes balance sheet restructuring, retires $41.6M in debt - MSN
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionNew Guidance & Risk Controlled Stock Alerts - thegnnews.com
Celularity Sells IP to Celeniv, Reduces Debt - MSN
Tick level data insight on Celularity Inc. volatilityJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Celularity Restructures Debt with Intellectual Property Sale to Celeniv - AInvest
Celularity Completes Balance Sheet Restructuring, Eliminates $41.6 Million in Senior Secured Debt - AInvest
Celularity's Strong Positioning and Financial Restructuring Drive Buy Rating - AInvest
Why Celularity Inc. Equity Warrant is moving todayWeekly Stock Recap & Safe Investment Capital Preservation Plans - Newser
What does recent volatility data suggest for Celularity Inc. Equity WarrantAnalyst Downgrade & Daily Price Action Insights - Newser
Momentum divergence signals in Celularity Inc. chart2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Can Celularity Inc. Equity Warrant hit a new high this monthRate Cut & Fast Exit and Entry Trade Guides - Newser
Is a relief rally coming for Celularity Inc. holdersTrade Analysis Report & Daily Volume Surge Signals - Newser
Published on: 2025-08-19 05:57:28 - Newser
What to do if you’re stuck in Celularity Inc. Equity WarrantMarket Growth Report & Weekly Top Gainers Trade List - Newser
Pattern recognition hints at Celularity Inc. Equity Warrant upsideLong Setup & Detailed Earnings Play Alerts - Newser
Can trapped investors hope for a rebound in Celularity Inc.Weekly Stock Recap & Daily Profit Maximizing Tips - Newser
Signal strength of Celularity Inc. stock in tech scannersQuarterly Trade Review & Reliable Entry Point Alerts - Newser
When is the best time to exit Celularity Inc. Equity WarrantQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Sentiment analysis tools applied to Celularity Inc.IPO Watch & Trade Opportunity Analysis - Newser
Using Bollinger Bands to evaluate Celularity Inc. Equity WarrantTreasury Yields & AI Powered Market Entry Ideas - Newser
Celularity Inc. Recovery Potential Based on Technical ToolsMarket Risk Report & Verified Short-Term Trading Plans - 선데이타임즈
Bollinger Band Squeeze Points to Volatility in Celularity Inc. Equity WarrantJuly 2025 Outlook & Community Consensus Stock Picks - 선데이타임즈
Is a relief rally coming for Celularity Inc. Equity Warrant holdersBuy Signal & Safe Capital Growth Plans - Newser
Visual trend scoring systems applied to Celularity Inc.Weekly Investment Report & Weekly High Conviction Ideas - Newser
Published on: 2025-08-18 22:55:18 - Newser
Celularity shares rise 3.61% after-hours after completing major balance sheet restructuring. - AInvest
Celularity completes balance sheet restructuring, retires $41.6mln senior secured debt. - AInvest
Celularity Receives New Coverage with Speculative Buy Rating from WBB Securities - AInvest
Celularity: WBB Securities initiates coverage with Speculative Buy, $6 price target. - AInvest
Celularity’s Strategic Positioning and Financial Restructuring Drive Buy Rating - TipRanks
Celularity completes major balance sheet restructuring - MarketScreener
Celularity retires all senior secured debt in restructuring deal By Investing.com - Investing.com Canada
Celularity retires all senior secured debt in restructuring deal - Investing.com
Celularity Completes Major Restructuring, Retires All $41.6 Million in Senior Secured Debt and Monetizes Intellectual Property Assets - AInvest
Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt - GlobeNewswire
Celularity Eliminates Senior Debt, Restructures, and Licenses Back IP Assets - AInvest
Celularity Inc. Retires All $41.6 Million in Senior Secured Debt - MarketScreener
Applying sector rotation models to Celularity Inc.July 2025 Closing Moves & Fast Entry and Exit Trade Plans - Newser
Celularity Enters Series Seed Stock Agreement with Defeye - MSN
Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsQuarterly Earnings Summary & Long-Term Capital Growth Strategies - Newser
How hedge fund analytics apply to Celularity Inc. Equity Warrant stockQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
What recovery options are there for Celularity Inc. Equity Warrant2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Is it too late to sell Celularity Inc. Equity WarrantQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
Forecasting Celularity Inc. Equity Warrant price range with options dataChart Signals & Risk Managed Investment Signals - Newser
Reversal indicators forming on Celularity Inc. Equity Warrant stockGap Down & Weekly Top Performers Watchlists - Newser
Published on: 2025-08-17 23:09:58 - Newser
Multi asset correlation models including Celularity Inc.Quarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
How to manage a losing position in Celularity Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
News impact scoring models applied to Celularity Inc.Inflation Watch & Fast Entry Momentum Alerts - Newser
Understanding Celularity Inc. Equity Warrant’s price movementJuly 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
Momentum Traders Eye Celularity Inc. Equity Warrant for Quick Bounce2025 Volatility Report & Precise Buy Zone Identification - sundaytimes.kr
Celularity Inc Stock (CELU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Celularity Inc Stock (CELU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):